BCV

DRUG2 trials

Sponsors

ViiV Healthcare, SymBio Pharmaceuticals

Conditions

Adenovirus InfectionsCytomegalovirus InfectionInfection, Human Immunodeficiency Virus

Phase 1

A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).

CompletedNCT01563328

ViiV HealthcareInfection, Human Immunodeficiency Virus

Start: 2012-03-01End: 2012-05-01Updated: 2017-03-28

Phase 2

A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection

RecruitingNCT04706923

SymBio PharmaceuticalsAdenovirus Infections, Cytomegalovirus Infection

Start: 2021-08-16End: 2026-09-30Target: 52Updated: 2024-06-21

Related Papers

P-103. Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study

Open Forum Infectious Diseases2025-01-291 citations

Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection

Blood2023-11-026 citations